Myelofibrosis: Long-Term Survival Data and Ruxolitinib Use

Описание к видео Myelofibrosis: Long-Term Survival Data and Ruxolitinib Use

Jamile Shammo, MD, discusses the long-term survival data and the use of ruxolitinib for patients with myelofibrosis.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Комментарии

Информация по комментариям в разработке